Why Inluriyo brings a new hope8 Signs and Symptoms of Breast Cancer Besides a LumpWhat is ESR1-mutated advanced breast cancerKey takeawaysFDA-approved the first oral therapy for ESR1-mutated advanced breast cancer called Inluriyo. A significant step towards the fight against breast cancer has come into existence. therapies.Existing treatments such as aromatase inhibitors or fulvestrant injections have improved survival, however, many breast cancer patients develop resistance linked to ESR1 mutations. Inluriyo prevents the tumor cells from using estrogen to survive and multiply.ESR1-mutated advanced breast cancer is a type of estrogen receptor (ER) positive breast cancer, where cancer cells have acquired mutations in the ESR1 gene. A report published by Webmd highlights that the oral drug Inluriyo can harm the unborn child during pregnancy, and breastfeeding is also not recommended during the treatment.Also See: Breast Cancer Symptoms: Breast Cancer Awareness Month: Here's what WHO warns about the combination of symptoms